Drug–drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer

PURPOSE: A microdose drug–drug interaction (DDI) study may be a valuable tool for anticipating drug interaction at therapeutic doses. This study aimed to compare the magnitude of DDIs at microdoses and regular doses to explore the applicability of a microdose DDI study. PATIENTS AND METHODS: Six hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Gab-jin, Bae, Soo Hyeon, Park, Wan-Su, Han, Seunghoon, Park, Min-Ho, Shin, Seok-Ho, Shin, Young G, Yim, Dong-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384691/
https://www.ncbi.nlm.nih.gov/pubmed/28408803
http://dx.doi.org/10.2147/DDDT.S131797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384691/
https://www.ncbi.nlm.nih.gov/pubmed/28408803
http://dx.doi.org/10.2147/DDDT.S131797

Ejemplares similares